ArticleFrontiers in pharmacology2025
Occupational 4-Methylsulfonyl-benzonitrile poisoning: a case report.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: 4-Methylsulfonyl-benzonitrile is an organic compound used in organic synthesis with applications in medicine, dye, and pesticide production. However, its toxicological characteristics in humans remain poorly understood, with no previously reported cases of poisoning. Case presentation: This report describes a 33-year-old male who developed severe toxic encephalopathy and peripheral neuropathy following occupational exposure during herbicide production. The patient worked without adequate personal protective equipment in a workshop where he was intermittently exposed to organic solvents, including 4-methylsulfonyl-benzonitrile, over several months. He initially presented with dizziness, slurred speech, and mental deterioration, which progressed to impaired consciousness and respiratory failure requiring mechanical ventilation. Blood analysis revealed an initial 4-methylsulfonyl-benzonitrile concentration of 734 ng/mL upon initial testing, decreasing to 76 ng/mL, and becoming undetectable within 10 days. Magnetic resonance imaging showed diffuse symmetric abnormalities in the corpus callosum, bilateral basal ganglia, corona radiata, and centrum semiovale. Electromyography confirmed sensorimotor peripheral neuropathy. Intervention and outcome: The patient received comprehensive treatment including mechanical ventilation, organ protection, neurotrophic therapy, anti-infective therapy, and nutritional support. After 28 days of hospitalization, he was discharged with significant improvement-conscious, oriented, and with normalized speech, although mild numbness in the limbs persisted. Conclusion: This case demonstrates that 4-methylsulfonyl-benzonitrile poisoning can induce both toxic encephalopathy and peripheral neuropathy. The findings highlight an urgent need to strengthen safety monitoring and safety training in chemical manufacturing enterprises.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.